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INTRODUCTION
PRP is used in various fields of medicine, such as
dentistry, orthopedics, and plastic surgery, to promote
early tissue healing and regeneration, and has re-
cently received recognition because of its increased
use in injured athletes.1 Platelets are important cells
that initiate wound healing. PRP is a normal autolo-
gous component of blood that contains many plate-
lets. There are three types of granules in platelets.
The α granules are storage granules containing
various growth factors, such as PDGF, VEGF and
CTGF. Growth factors released from platelets be-
come active through the coagulation process, and
their release upon the destruction of α granules
stimulates tissue regeneration. Previous studies have
reported that PRP significantly induces the prolifera-
tion of various cells, such as human adipose-derived
stem cells, human dermal fibroblasts,2 periodontal
ligament cells,3 and alveolar bone cells.4 A recent
study reported that PRP injection into the knee joint
promoted cartilage healing. However, there are few
studies dealing with synovial cells, and the effect of
PRP on proliferation of human synovial cells is uncer-
tain. We investigated the influence of PRP on human
synovial cells to clarify the clinical efficacy of PRP for
synovial membrane tissue injury associated with tem-
poromandibular joint disorder and related diseases in
the field of oral surgery.5
MATERIALS AND METHODS
Cell culture
The patient was a 21-year-old male who gave in-
formed consent. Surgical specimens of human
synovium were obtained during arthroscopic knee
surgery. The synovial cell culture was prepared based
on the methods of previous studies.6, 7 Briefly, speci-
mens of synovium was minced, and digested with
0.2% collagenase in DMEM. The liberated cells were
resuspended in DMEM with 10% fetal bovine serum
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(FBS) and 1% penicillin-streptomycin. Cells were cul-
tured in a monolayer at 37°C in a 5% CO2 atmos-
phere. Cells from the third to seventh passage were
used in this study.
PRP preparation
PRPwas prepared employing the double spinmethod
based on a previous study2 using a PRP kit (BSMedi-
cal, Tokyo, Japan). Briefly, blood was collected from
the healthy 29-year-old male volunteer into a tube
containing acid-citrate-dextrose solution formula A
(1 : 7 vol/vol) anticoagulant, and centrifuged at 500 x
G for 7 min using a conventional centrifuge available
at the experimental facility. Plasma and buffy-coat
were collected into a blood sampling tube containing
no anticoagulant, followed by a second centrifugation
at 1600 x G for 5 min, and 1 mL of the thrombocyte
pellet precipitated on the tube bottomwas used as the
PRP. Activator was prepared by mixing 0.5 M of cal-
cium hydrochloride and autologous thrombin. Acti-
vated PRP (aPRP) was made by combining the pellet
with the activator at 10 : 1. The mixture was centri-
fuged at 13,200 rpm for 15 min, and the supernatant
was collected and stored at −80°C.
Determination of the protein concentrations of
PDGF-AB in PRP and aPRP
PDGF-AB levels in PRP and aPRP were determined
by a commercially available sandwich enzyme-linked
immunosorbent assay technique kit (Quantikine ; R
&D Systems, Minneapolis, MN, USA) to confirm that
the PRP was activated.
Cell proliferation assay
The obtained human synovial cells were seeded in a
96-well dish at 1.0 x 103 cells /well. After confirming
that cells had adhered to the dish, 5% PRP, 5%
aPRP, and 10% FBS were added and the cells were
cultured for 5 days as Experiment 1 (n＝5). In Experi-
ment 2, cells were cultured with 1, 5, 10 and 20%
aPRP and 10% FBS (control) for 1, 3 and 5 days (n
＝5). Cell proliferation was examined using a Cell
Counting Kit-8 (Dojindo Molecular Technologies,
Gaithersburg, MD, USA), and cells were counted fol-
lowing the manufacturer’s instructions. The number
of cells on the fifth day was confirmed under a micro-
scope.
Determination of interleukin protein concentra-
tions in the culture media
In Experiment 3, human synovial cells were seeded in
a 12-well dish at 1.0 x 104 cells /well. After confirming
that cells had adhered to the dish, 1, 5, 10 and 20%
aPRP and 10% FBS were added and the cells were
cultured for 5 days, we determined the protein con-
centrations of the interleukins (IL-1β , IL-6, IL-8) in cul-
ture media. The concentrations were determined us-
ing the Artemis TR-FRET Microplate Reader for
HTRF® (Cosmo Bio) with HTRF® package insert re-
agents (Cisbio) following the manufacturer’s instruc-
tions.
Statistical analysis
One-way ANOVA was used for comparison among
the groups. Statistical significance was established at
the p＜0.05 level. Data are presented as means the
mean and standard deviation.
RESULTS
Blood test
Blood testing was performed by LSI Medience. The
test results are shown in Table 1. The platelet counts
Table 1 Blood tested by LSI Medience
WBC
(μ l)
RBC
(×104/μ l)
HGB
(g/dL)
HCT
(%)
PLT
(×104/ml)
Whole blood
PRP
PPP
4750±212.1
18600±565.6
471.5±7.7
531.5±23.3
13.4±0.2
14.9±0.4
40.5±0.2
46.7±2.1
24.5±0.2
156.6±41.2
9.2±7.4
PRP : Platelet-rich plasma, PPP : Platelet-poor plasma.
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for PPP and PRP were 9.2±7.4 and 156.6±41.2, re-
spectively, showing that the count for PRP was about
10 times higher. The PRP platelet count had previ-
ously been reported to be about 7 times higher.2 This
was close to our count, demonstrating that we had
successfully prepared the PRP.
PDGF-AB levels in prepared PRP and aPRP
The PDGF-AB levels in aPRP was about 30 times
higher than those in PRP (data not shown).
Effect of PRP on proliferation of human synovial
cells
On day 5 of the culture in Experiment 1, the prolifera-
tion of human synovial cells was significantly greater
with the 5% aPRP compared with the 5%PRPand the
10% FBS (Fig. 1). In Experiment 2, rapid growth was
noted from day 3 in the 5, 10 and 20% aPRP com-
bined groups, and significant differences were noted
Fig. 1 Human synovial cell proliferation on day 5 after the addi-
tion of 10% FBS, 5% PRP and 5% aPRP (*p＜0.05, n＝5).
Fig. 3 Microscopic images of the proliferation of human synovial
cells.
Fig. 2 Human synovial cell proliferation on days 1, 3 and 5 after
the addition of various concentrations of activated platelet-rich
plasma (a : p＜0.05, versus 1% aPRP, b : p＜0.05, versus 10%
FBS, n＝5).
Fig. 4 Protein concentrations of IL-6, IL-8, and IL-1β in culture media on day 5 after the addition
of various concentrations of activated platelet-rich plasma (*p＜0.05, n＝5).
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on day 5 of culture compared to growth in the 10%
FBS and 1%PRP groups (Fig. 2). Microscopic exami-
nation revealed that the number of cells increased in
a concentration-dependent manner (Fig. 3). In Experi-
ment 3, no significant difference was noted in the IL-
1β level of the culture supernatant among the
groups. However, the IL-6 and IL-8 protein production
levels increased in a concentration-dependent man-
ner, showing significant differences (Fig. 4), and 5%
aPRP was the lowest in the relative values per cell
(Fig. 5).
DISCUSSION
The synovial membrane closely adheres to the inner
surface of the articular capsule in the temporomandi-
bular joint, and the upper and lower articular spaces
are individually lined. The synovial membrane pro-
duces synovial fluid, lubricates the joint, and nour-
ishes the joint cartilage and disc. When the articular
disc dislocates forward due to temporomandibular
joint disorder, the synovial membrane attached to the
posterior tissue of the disc directly receives amastica-
tory load, and this excess loading induces inflamma-
tion, causing injury and perforation of the synovial
membrane, For this reason, we studied PRP which is
frequently used to promote early tissue healing and
regeneration. We investigated the influence of PRP
on human synovial cells to clarify its clinical efficacy
for treatment of temporomandibular joint disorder-as-
sociated synovial membrane tissue injury. Experi-
ment 1 clarified that aPRP more markedly promoted
synovial cell proliferation, suggesting the involvement
of PDGF released from destroyed and activated plate-
lets. PDGF has been reported to induce fibroblast pro-
liferation.8 We also observed significant synovial
membrane growth in the aPRP group.
Experiment 2 clarified that cell proliferation was en-
hanced when the aPRP level was 5-20%. A previous
study reported that alveolar bone cell proliferation was
most markedly promoted at 5-10 %.4 We observed
aPRP concentration-dependent synovial cell prolif-
eration. However, longer-term observation may be
necessary because the duration of our experimental
measurement was short (5 days), and it has been
suggested that a high PRP creates cytotoxicity.4
A correlation between inflammatory findings of the
synovial membrane on arthroscopy and temporoman-
dibular joint pain has been reported.9 Various proin-
flammatory cytokines, such as IL-1β , IL-6, and IL-8
have been measured in the synovial membrane and
in fluid collected from patients with degenerative
changes in the temporomandibular joint and osteoar-
thritis.10, 11 The results of Experiment 3 demonstrated
significant increases in the measured values of IL-6
and -8. However, those of Experiment 2 show that the
proliferation rate of synovial cells was increased by
raising the concentration of PRP, with the productions
of IL-6 and -8 also increased in a concentration-de-
pendent manner. Hence, 5% aPRP was the lowest
relative value per cell among IL-1β , -6, and -8. Thus,
we determined an optimal concentration of 5%. How-
ever, reportedly, matrix metalloproteinases (MMPs)
are produced in synovial fibroblasts on day 2 after the
addition of PRP.12, 13 Thus, further studies are needed
in the future. We found that aPRP promoted prolifera-
tion of human synovial cells more than did PRP, and
that it promoted this proliferation in a concentration-
dependent manner. This study suggests that PRP ef-
fectively promotes proliferation of human synovial
cells.
Fig. 5 The relative values per cell on protein concentrations of IL-6, IL-8, and IL-1β (*p＜0.05, n＝5).
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